Brief: Fusion Antibodies Announces Contract Wins With Existing Client
27/08/2025 07:25
Aug 27 (Reuters) - Fusion Antibodies PLC FAB.L: FUSION ANTIBODIES - CONTRACT WINS WITH EXISTING CLIENT FUSION ANTIBODIES - SELECTED TO PROCEED WITH 3 FOLLOW ON PROJECTS TO STABLE CELL LINE DEVELOPMENT PROJECT; NEW CONTRACTS ARE VALUED AT C. $460,000 Source text: ID:nRSa7388Wa Further company coverage: FAB.L ((Reuters.Briefs@thomsonreuters.com))
Recent news on Fusion Antibodies
See all newsBrief: Fusion Antibodies Announces New TGE And Cryoem Project With US Pharma Client
Fusion Antibodies - Contract win
Fusion Antibodies - AGM statement H1 trading and research update
RCS - Fusion Antibodies - Launch of new customer-focused website
Fusion Antibodies - Posting of Annual Report & Notice of AGM